- Home
- CRIS vs SHFS Comparison
CRIS vs SHFS Comparison
Compare CRIS & SHFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- SHFS
- Stock Information
- Founded
- CRIS 2000
- SHFS 2015
- Country
- CRIS United States
- SHFS United States
- Employees
- CRIS N/A
- SHFS N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- SHFS Finance: Consumer Services
- Sector
- CRIS Health Care
- SHFS Finance
- Exchange
- CRIS Nasdaq
- SHFS Nasdaq
- Market Cap
- CRIS 21.3M
- SHFS 20.8M
- IPO Year
- CRIS 2000
- SHFS N/A
- Fundamental
- Price
- CRIS $2.37
- SHFS $2.47
- Analyst Decision
- CRIS Strong Buy
- SHFS
- Analyst Count
- CRIS 2
- SHFS 0
- Target Price
- CRIS $16.50
- SHFS N/A
- AVG Volume (30 Days)
- CRIS 76.2K
- SHFS 17.9K
- Earning Date
- CRIS 07-31-2025
- SHFS 05-21-2025
- Dividend Yield
- CRIS N/A
- SHFS N/A
- EPS Growth
- CRIS N/A
- SHFS N/A
- EPS
- CRIS N/A
- SHFS N/A
- Revenue
- CRIS $11,202,000.00
- SHFS $13,956,453.00
- Revenue This Year
- CRIS $0.93
- SHFS N/A
- Revenue Next Year
- CRIS $8.10
- SHFS N/A
- P/E Ratio
- CRIS N/A
- SHFS N/A
- Revenue Growth
- CRIS 14.17
- SHFS N/A
- 52 Week Low
- CRIS $1.02
- SHFS $1.84
- 52 Week High
- CRIS $9.72
- SHFS $14.86
- Technical
- Relative Strength Index (RSI)
- CRIS 59.94
- SHFS 44.83
- Support Level
- CRIS $2.23
- SHFS $2.02
- Resistance Level
- CRIS $2.63
- SHFS $2.80
- Average True Range (ATR)
- CRIS 0.18
- SHFS 0.25
- MACD
- CRIS 0.03
- SHFS 0.05
- Stochastic Oscillator
- CRIS 67.09
- SHFS 61.29
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About SHFS SHF Holdings Inc.
SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring among others.